PLEK2 and neoplasm: Although pleckstrin family members such as PLEK2 and CNK1 have been implicated in tumor progression through PI3K-Akt signaling and KRAS-mediated immune modulation (38, 57–59), the role of classical PLEK (Plek1) in solid tumors remains largely unexplored.